Genetic polymorphisms in chitinase 3-like 1 (CHI3L1) are associated with circulating YKL-40 levels, but not with angiographic coronary artery disease in a Chinese population

Cytokine

Volumn 54, Issue 1, 2011, Pages 51-55

  Zheng, Jian Lei ^a   Lu, Lin ^a   Hu, Jian ^a   Zhang, Rui Yan ^a   Zhang, Qi ^a   Chen, Qiu Jin ^a   Shen, Wei Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Coronary artery disease; Inflammation; Polymorphism; YKL 40

Indexed keywords

APOLIPOPROTEIN B; CHITINASE; CHITINASE 3 LIKE 1; CREATININE; GLYCOPROTEIN GP 39; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMORPHIC LOCUS; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPOKINES; AGED; ANGIOGRAPHY; CHINA; CORONARY ARTERY DISEASE; FEMALE; GENETIC VARIATION; GENOTYPE; GLYCOPROTEINS; HAPLOTYPES; HUMANS; LECTINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROMOTER REGIONS, GENETIC;

EID: 79952070571     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.12.018     Document Type: Article

References (28)

1. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
2. Boot R.G., van Achterberg T.A.E., van Aken B.E., Renkema G.H., Jacobs M.J., Aerts J.M., et al. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 1999, 19:687-694.
3. Volck B., Price P.A., Johansen J.S., Sørensen O., Benfield T.L., Nielsen H.J., et al. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians 1998, 110:351-360.
4. Shackelton L.M., Mann D.M., Millis A.J. Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodelling. J Biol Chem 1995, 270:13076-13083.
5. Rathcke C.N., Vestergaard H. YKL-40 - an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol 2009, 8:61.
6. Kucur M., Isman F.K., Karadag B., Vural V.A., Tavsanoglu S. Serum YKL-40 levels in patients with coronary artery disease. Coron Artery Dis 2007, 18:391-396.
7. Zheng J.L., Lu L., Hu J., Zhang R.Y., Zhang Q., Chen Q.J., et al. Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease. Atherosclerosis 2010, 210:590-595.
8. Kastrup J., Johansen J.S., Winkel P., Hansen J.F., Hildebrandt P., Jensen G.B., et al. High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease. Eur Heart J 2009, 30:1066-1072.
9. Zhao X., Tang R., Gao B., Shi Y., Zhou J., Guo S., et al. Functional variants in the promoter region of chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia. Am J Hum Genet 2007, 80:12-18.
10. Ober C., Tan Z., Sun Y., Possick J.D., Pan L., Nicolae R., et al. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 2008, 358:1682-1691.
11. Berres M.L., Papen S., Pauels K., Schmitz P., Zaldivar M.M., Hellerbrand C., et al. A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection. J Hepatol 2009, 50:370-376.
12. Kruit A., Grutters J.C., Ruven H.J., van Moorsel C.C., van den Bosch J.M. CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respir Med 2007, 101:1563-1571.
13. Sohn M.H., Lee J.H., Kim K.W., Kim S.W., Lee S.H., Kim K.E., et al. Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy. Am J Respir Crit Care Med 2009, 179:449-456.
14. Nielsen A.R., Erikstrup C., Johansen J.S., Fischer C.P., Plomgaard P., Krogh-Madsen R., et al. Plasma YKL-40, a BMI-independent marker of type 2 diabetes. Diabetes 2008, 57:3078-3082.
15. Rathcke C.N., Persson F., Tarnow L., Rossing P., Vestergaard H. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care 2009, 32:323-328.
16. Brasselet C., Tassan S., Nazeyrollas P., Hamon M., Metz D. Randomised comparison of femoral versus radial approach for percutaneous coronary intervention using abciximab in acute myocardial infarction: results of the FARMI trial. Heart 2007, 93:1556-1561.
17. Solymoss B.C., Bourassa M.G., Campeau L., Sniderman A., Marcil M., Lespérance J., et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004, 93:159-164.
18. Montorsi P., Ravagnani P.M., Galli S., Rotatori F., Veglia F., Briganti A., et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J 2006, 27:2632-2639.
19. Solé X., Guinó E., Valls J., Iniesta R., Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929.
20. Nojgaard C., Host N.B., Christensen I.J., Poulsen S.H., Egstrup K., Price P.A., et al. Serum levels of YKL-40 increases in patients with acute myocardial infarction. Coron Artery Dis 2008, 19:257-263.
21. Whiting B.M., Anderson J.L., Muhlestein J.B., Horne B.D., Bair T.L., Pearson R.R., et al. Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease. Am Heart J 2005, 150:243-250.
22. Michelsen A.E., Rathcke C.N., Skjelland M., Holm S., Ranheim T., Krohg-Sørensen K., et al. Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 2010, 211:589-595.
23. Duff G.W. Influence of genetics on disease susceptibility and progression. Nutr Rev 2007, 65:S177-S181.
24. Tiret L. Gene-environment interaction: a central concept in multifactorial diseases. Proc Nutr Soc 2002, 61:457-463.
25. Bozzi A., Reis B.S., Pereira P.P., Pedroso E.P., Goes A.M. Interferon-gamma and interleukin-4 single nucleotide gene polymorphisms in Paracoccidioidomycosis. Cytokine 2009, 48:212-217.
26. Yeh K.Y., Li Y.Y., Hsieh L.L., Chen J.R., Tang R.P. The -174G/C polymorphism in interleukin-6 (IL-6) promoter region is associated with serum IL-6 and carcinoembryonic antigen levels in patients with colorectal cancers in Taiwan. J Clin Immunol 2010, 30:53-59.
27. Johansen J.S., Lottenburger T., Nielsen H.J., Jensen J.E., Svendsen M.N., Kollerup G., et al. Diurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects. Cancer Epidemiol Biomarkers Prev 2008, 17:2603-2608.
28. Tuzcu E.M., Kapadia S.R., Tutar E., Ziada K.M., Hobbs R.E., McCarthy P.M., et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 2001, 103:2705-2710.